Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRiVE SaFe: Intranasal esketamine and on-road driving performance study
NL-OMON40941Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in treatment-resistant depression (TRD) and major depressive disorder (MDD) (3 arms), sponsored by Janssen Pharmaceutical. Started Sep 2014; status: active, not recruiting.
02
Drugs
esketamine
03
Conditions
treatment-resistant depression (TRD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON40941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40941.